View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB39 Publication ID: Fall 2015 
Title: ●Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Vicks® VapoInhaler® 
Abstract:

The Drug Enforcement Administration (DEA) is amending the table of Excluded Nonnarcotic Products to update the listing for Vicks ® VapoInhaler ® , containing 50 mg levmetamfetamine in a nasal decongestant inhaler, marketed by The Proctor & Gamble Company. This over-the-counter, non-narcotic drug product is excluded from provisions of the Controlled Substances Act.

 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1308.21    21 CFR 1308.22   
Legal Authority: 21 U.S.C. 811(g)(1)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Interim Final Rule  01/00/2016 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Demetra Ashley
Associate Deputy Assistant Administrator
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:202 307-7165